Mostrar o rexistro simple do ítem

dc.contributor.authorVilar-Villanueva, M.*
dc.contributor.authorSomoza Martín, José Manuel*
dc.contributor.authorBlanco Carrión, Andrés*
dc.contributor.authorGarcía García, Abel *
dc.contributor.authorGarcía-Carnicero, T.*
dc.contributor.authorMarichalar-Mendía, X.*
dc.contributor.authorGallas Torreira, Mercedes*
dc.contributor.authorGándara Vila, Pilar *
dc.date.accessioned2025-09-09T12:42:01Z
dc.date.available2025-09-09T12:42:01Z
dc.date.issued2023
dc.identifier.citationVilar-Villanueva M, Somoza-Martín JM, Blanco-Carrión A, García-García A, García-Carnicero T, Marichalar-Mendía X, et al. Importance of the vaporization margin during CO2 laser treatment of oral leukoplakia: A survival study. Oral Diseases. 2023;29(7):2689-95.
dc.identifier.issn1601-0825
dc.identifier.otherhttps://portalcientifico.sergas.gal//documentos/631ce8e363e72b10525632e3
dc.identifier.urihttp://hdl.handle.net/20.500.11940/21616
dc.description.abstractObjectives: The main purpose of this study was to assess the response of oral leukoplakia to CO2 laser vaporization treatment, as well as determining possible factors that may affect recurrence of lesions. Materials and methods: A retrospective study was conducted, in which the medical records of patients who had been clinically and histologically diagnosed with oral leukoplakia and treated with CO2 laser between 1996 and 2019 at the Oral Medicine Teaching Unit of the Faculty of Dentistry of the University of Santiago de Compostela were reviewed. Results: Fifty-eight patients were included: 36 female and 22 male subjects, with a mean age of 63.7 years old (SD ±13.1). The average follow-up time was 57.5 months (SD ±57.9). A relapse rate of 52.6% was determined. Of all the studied variables, the margin was the only one for which a statistically significant association with recurrence of lesions was demonstrated (p < 0.05). Conclusion: The vaporization of lesions using CO2 laser with a safety margin of at least 3 mm from the clinical limits of OL is a key factor in preventing recurrence.
dc.languageeng
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshHumans *
dc.subject.meshMale *
dc.subject.meshFemale *
dc.subject.meshMiddle Aged *
dc.subject.meshCarbon Dioxide *
dc.subject.meshRetrospective Studies *
dc.subject.meshVolatilization *
dc.subject.meshNeoplasm Recurrence, Local*
dc.subject.meshLeukoplakia, Oral *
dc.subject.meshLaser Therapy *
dc.subject.meshLasers, Gas *
dc.titleImportance of the vaporization margin during CO2 laser treatment of oral leukoplakia: A survival study
dc.typeArtigo
dc.authorsophosVilar-Villanueva, M.; Somoza-Martín, J.M.; Blanco-Carrión, A.; García-García, A.; García-Carnicero, T.; Marichalar-Mendía, X.; Gallas-Torreira, M.; Gándara-Vila, P.
dc.identifier.doi10.1111/odi.14345
dc.identifier.sophos631ce8e363e72b10525632e3
dc.issue.number7
dc.journal.titleOral Diseases*
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Santiago::Cirurxía maxilofacial
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
dc.organizationInstituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
dc.page.initial2689
dc.page.final2695
dc.relation.publisherversionhttps://doi.org/10.1111/odi.14345
dc.rights.accessRightsopenAccess*
dc.subject.keywordAS Santiago
dc.subject.keywordIDIS
dc.subject.keywordAS Santiago
dc.subject.keywordCHUS
dc.subject.keywordAS Santiago
dc.subject.keywordIDIS
dc.subject.keywordIDIS
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)
dc.typesophosArtículo Original
dc.volume.number29


Ficheiros no ítem

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem

Attribution-NonCommercial-NoDerivatives 4.0 International
A non ser que se indique outra cousa, a licenza do ítem descríbese comoAttribution-NonCommercial-NoDerivatives 4.0 International